Mutations in amyloid precursor protein (APP) and preselinins are associated with familial Alzheimer’s disease (fAD), which constitutes around 1% of AD cases [1], and are the cause of overproduction of amyloid β (Aβ) peptides [2,3]. This evidence concerns the gene APP and familial Alzheimer disease.